Levacetylleucine

N/A

Report date: 2026/05/22 16:38:42
NME

Base Information

Drug NameLevacetylleucine
Drug Alias NameL-乙酰亮氨酸Acetyl-L-leucineN-acetyl-L-leucineL-AcetylleucineAQNEURSA +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabolism modulators
TargetsNot applicable
Therapy Area/IndicationsAtaxiaMigraine DisordersAtaxia Telangiectasia +[9] 
Global Approved IndicationsNiemann-Pick Disease, Type C
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2024/09/24
Country/TerritoryCzechiaUnited StatesSlovakia +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPierre Fabre Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIntrabio Ireland LtdIntrabio Inc
Inactive CompaniesPierre Fabre Medicament
Active IndicationsAtaxiaMigraine DisordersAtaxia Telangiectasia +[8] 
Inactive IndicationsVertigo

Other Information

ATC CodeN/A
Related LinksN/A